https://www.zonebourse.com/cours/action/MINK-THERAPEUTICS-INC-128249930/actualite/MiNK-Therapeutics-Inc-annonce-le-premier-patient-dans-l-etude-de-phase-2-sur-l-agenT-797-dans-le-45955109/?utm_source=telegram&utm_medium=social&utm_campaign=share